The Joint Committee on Vaccination and Immunisation (JCVI) has advised that as of Monday 19th July, vulnerable children at increased risk of Covid-19 are being offered the Pfizer-BioNTech vaccine. This includes children aged between 12-15 with severe neurodisabilities, Down’s syndrome, immunosuppression and multiple or severe learning disabilities. The Pfizer-BioNTech vaccine is currently the only vaccine that has been authorised for children in the UK, for those aged 12 or older. The JCVI is not currently advising vaccination of children outside of these groups, until more research into possible side effects has been carried out.
Latest News Stories
- 52% of disabled music fans avoid gigs due to lack of accessibility
- Publication of Schools White Paper delayed until early 2026
- ‘Publicly humiliated’: parents describe difficulty of children’s isolation at school
- Disabled woman says parking revamp reduces access
- Appeal to make Manchester arts venue fully accessible to help disabled artists thrive